Intracranial drug balloon

By designing nylon tubes and intracranial drug balloons with high-density polyethylene materials, the problem of poor catheter passage caused by drug carriers is solved, and the rapid release of drugs and vascular penetration is achieved, achieving ideal therapeutic effect.

CN119075152APending Publication Date: 2024-12-06南京友德邦医疗科技有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411405701.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-10
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing intracranial drug balloon catheters have increased the wall thickness of the drug coating due to the drug carrier, which leads to an increase in the outer diameter of the balloon and deteriorates throughput. It is difficult for the drug to fully enter the blood vessel wall in the narrow blood vessels, making it impossible to achieve ideal treatment. Effect.

Method used

A intracranial drug balloon including catheter seat, hyperbar tube, visual marker, proximal structure, distal structure and accommodating structure was designed to provide strength and toughness using nylon tubes and high-density polyethylene materials to ensure the balloon Stable dilation in the blood vessels and rapid drug release.

Benefits of technology

Through the stable expansion of the balloon and the rapid release of the drug, effective treatment of blood vessels is achieved, ensuring the penetration and therapeutic effect of the drug in the stenotic blood vessels.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119075152A_ABST
    Figure CN119075152A_ABST
Patent Text Reader

Abstract

The invention relates to the field of medicine balloons, in particular to an intracranial medicine balloon which comprises a catheter seat, a near-end structure, a far-end structure and a containing structure, a hypotube is connected to the right end of the catheter seat, a visual mark is arranged on the outer wall of the hypotube, and the near-end structure is arranged at the right end of the hypotube. The balloon is sent to a preset arterial blood vessel through balloon dilatation for dilation, the balloon is sent to a narrow blood vessel position, the balloon is supported after pressure is set up, the effects of dilating local blood vessels and relieving local blood vessel stenosis are achieved, after the balloon is dilated, the drug coating on the surface is attached to the blood vessel wall, the drug is rapidly released to a target blood vessel, and the drug release effect is good. And the treatment effect is achieved, the balloon is stably supported, paclitaxel can rapidly permeate into the blood vessel wall to exert the drug effect within the single balloon dilatation time, and the blood vessel permeation treatment effect is guaranteed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of drug balloons, in particular to an intracranial drug balloon. Background Art

[0002] The good effect of drug-coated balloons in the interventional treatment of coronary artery disease provides a good reference for the interventional treatment of ischemic cerebrovascular disease. Therefore, whether DCB is used as a remedial measure for ISR, or its "intervention without implantation" reserves the opportunity for follow-up treatment when necessary for patients, these will become a trend in the future of endovascular interventional treatment of intracranial atherosclerotic stenosis.

[0003] Existing intracranial drug-eluting balloon catheters generally adopt the same delivery rod structure design as coronary drug-eluting balloon catheters, with the proximal stainless steel tube and the distal stainless steel wire welded;

[0004] However, the existing drug-eluting balloon catheters commonly used for intracranial artery stenosis mainly come from coronary drug-eluting balloon catheters, which usually add a drug coating on the surface of an ordinary dilatation balloon. The drug coating is composed of a drug carrier and a drug. The drug carrier increases the wall thickness of the drug coating, resulting in an increase in the outer diameter of the balloon, which makes the balloon catheter less passable in tortuous or narrow blood vessels. Since the drug carrier covers part of the drug, the drug cannot fully enter the blood vessel wall, making it difficult to achieve the ideal therapeutic effect. Summary of the invention

[0005] The purpose of the present invention is to provide an intracranial drug-eluting balloon, which is used to solve the problem that the existing drug-eluting balloon catheter commonly used for intracranial artery stenosis mainly comes from the coronary drug-eluting balloon catheter, which usually adds a drug coating on the surface of an ordinary dilatation balloon. The drug coating is composed of a drug carrier and a drug. The drug carrier increases the wall thickness of the drug coating, resulting in an increase in the outer diameter of the balloon, which makes the balloon catheter less passable in tortuous or narrow blood vessels. Since the drug carrier covers part of the drug, the drug does not fully enter the blood vessel wall, making it difficult to achieve an ideal therapeutic effect.

[0006] Therefore, the present invention provides an intracranial drug balloon, comprising a catheter seat, a proximal structure, a distal structure and a containing structure, wherein the right end of the catheter seat is connected to a hypotube, the outer wall of the hypotube is provided with a visual mark, the right end of the hypotube is provided with a proximal structure, the right end of the proximal structure is connected to the distal structure, the right end of the distal structure is provided with a retractable containing structure, the right end of the containing structure is provided with a tip, the right end of the tip is connected to a protective wire, and the right end of the protective wire is connected to a protective cover.

[0007] Preferably, the proximal structure comprises a transition tube, the right end of the transition tube is connected to a proximal outer tube, and a reinforcing wire is arranged at the center of the proximal outer tube.

[0008] Preferably: the distal structure includes a side port, the right end of the side port is connected to a distal outer tube, a distal inner tube is arranged inside the distal outer tube, a first nylon tube is arranged inside the distal inner tube, a first low-density tube is arranged inside the first nylon tube, and a first high-density tube is arranged inside the first low-density tube.

[0009] Preferably: the containing structure comprises a second high-density tube, a second low-density tube is sheathed on the outside of the second high-density tube, a second nylon tube is sheathed on the outer wall of the second low-density tube, a distal inner tube is sheathed on the outside of the second nylon tube, a balloon is arranged on the outside of the distal inner tube, and a drug coating is arranged on the outside of the balloon.

[0010] Preferably: the reinforcing wire is made of stainless steel.

[0011] Preferably, the first low-density tube and the second low-density tube are both made of linear low-density polyethylene.

[0012] Preferably, the first high-density tube and the second high-density tube are both made of high-density polyethylene.

[0013] Preferably, the first nylon tube and the second nylon tube are both made of nylon elastomer.

[0014] Preferably: a mark is arranged inside the distal inner tube.

[0015] Compared with the prior art, the present invention has the following beneficial effects:

[0016] The invention extends a smooth protective sleeve into an arterial blood vessel, delivers a balloon into a predetermined arterial blood vessel for expansion through balloon dilatation, delivers the balloon to a narrowed blood vessel, builds up pressure and props up the balloon, thereby expanding the local blood vessel and alleviating the narrowing of the local blood vessel. After the balloon is expanded, the drug coating on the surface is attached to the blood vessel wall, and the drug is quickly released to the target blood vessel to achieve a therapeutic effect. The first high-density tube, the first nylon tube, the first low-density tube, the second high-density tube, the second nylon tube and the second low-density tube provide effective contraction and expansion due to the high strength, good toughness, high rigidity, heat resistance and cold resistance of the nylon elastomer, high-density polyethylene and linear low-density polyethylene, thereby achieving stable support for the balloon, enabling paclitaxel to quickly penetrate into the blood vessel wall within a single balloon dilatation time to exert its efficacy, thereby ensuring the effect of blood vessel penetration therapy. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 It is a schematic diagram of the three-dimensional structure of the present invention;

[0018] Figure 2 It is a cross-sectional view of the CC section of the present invention;

[0019] Figure 3 It is a cross-sectional view of section BB of the present invention;

[0020] Figure 4 It is a cross-sectional view of section AA of the present invention.

[0021] In the figure:

[0022] 1. Catheter seat; 2. Hypotube; 3. Visual marker; 401. Transition tube; 402. Proximal outer tube; 403. Reinforcement wire; 501. Side port; 502. Distal outer tube; 503. First high-density tube; 504. Distal inner tube; 505. First nylon tube; 506. First low-density tube; 601. Drug coating; 602. Second high-density tube; 603. Balloon; 604. Distal inner tube; 605. Second nylon tube; 606. Second low-density tube; 7. Tip; 8. Protective wire; 9. Protective sleeve. DETAILED DESCRIPTION

[0023] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0024] Example 1

[0025] See also Figure 1-4 , the figure shows a preferred embodiment of the present invention, an intracranial drug balloon, comprising a catheter seat 1, a proximal structure, a distal structure and a containing structure, the right end of the catheter seat 1 is connected to a hypotube 2, the outer wall of the hypotube 2 is provided with a visual mark 3, the right end of the hypotube 2 is provided with a proximal structure, the right end of the proximal structure is connected to the distal structure, the right end of the distal structure is provided with a retractable containing structure, the right end of the containing structure is provided with a tip 7, the right end of the tip 7 is connected to a protective wire 8, and the right end of the protective wire 8 is connected to a protective sleeve 9.

[0026] It should be noted that the proximal structure, distal structure and containing structure of the present solution improve the use effect of the drug balloon 603.

[0027] The proximal structure includes a transition tube 401 , the right end of which is connected to a proximal outer tube 402 , and a reinforcing wire 403 is disposed at the center of the proximal outer tube 402 .

[0028] It should be noted that this solution makes the structure more stable.

[0029] Wherein, the reinforcing wire 403 is made of stainless steel.

[0030] It should be noted that this solution makes the structure stable and complete.

[0031] Example 2

[0032] See also Figure 1-4 The distal structure includes a side port 501, the right end of which is connected to a distal outer tube 502, a distal inner tube 504 is arranged inside the distal outer tube 502, a first nylon tube 505 is arranged inside the distal inner tube 504, a first low-density tube 506 is arranged inside the first nylon tube 505, and a first high-density tube 503 is arranged inside the first low-density tube 506.

[0033] It should be noted that this solution makes the drug application structure more functional.

[0034] The first low-density tube 506 and the second low-density tube 606 are both made of linear low-density polyethylene.

[0035] It should be noted that this solution improves the toughness of the pesticide application structure.

[0036] Wherein, the first high-density tube 503 and the second high-density tube 602 are both made of high-density polyethylene.

[0037] It should be noted that this solution makes the spraying structure strong.

[0038] Wherein, the first nylon tube 505 and the second nylon tube 605 are both made of nylon elastomer.

[0039] It should be noted that: this solution enables the pesticide application structure to be used more stably.

[0040] Example 3

[0041] See also Figure 1-4 The containing structure includes a second high-density tube 602, a second low-density tube 606 is sheathed on the outside of the second high-density tube 602, a second nylon tube 605 is sheathed on the outer wall of the second low-density tube 606, a distal inner tube 604 is sheathed on the outside of the second nylon tube 605, a balloon 603 is arranged on the outside of the distal inner tube 604, and a drug coating 601 is arranged on the outside of the balloon 603.

[0042] It should be noted that this solution facilitates the rapid release of drugs.

[0043] Wherein, a mark is arranged inside the distal inner tube 604 .

[0044] It should be noted that this solution is convenient for marking locations.

[0045] The working process and principle of the present invention are as follows: the smooth protective sheath 9 is inserted into the artery, and the balloon 603 is sent to the predetermined artery for expansion through balloon dilatation, and the balloon 603 is sent to the narrowed blood vessel, and the pressure is built up to prop up the balloon 603, so as to achieve the effect of expanding the local blood vessel and alleviating the local blood vessel stenosis. After the balloon 603 is expanded, the drug coating 601 on the surface is attached to the blood vessel wall, and the drug is quickly released to the target blood vessel to achieve the therapeutic effect. The first high-density tube 503, the first nylon tube 505, the first low-density tube 506, the second high-density tube 602, the second nylon tube 605 and the second low-density tube 606 provide effective contraction and expansion due to the high strength, good toughness, high rigidity, heat resistance and cold resistance of the nylon elastomer, high-density polyethylene and linear low-density polyethylene, so as to achieve stable support for the balloon 603, so that paclitaxel can quickly penetrate into the blood vessel wall within the time of a single balloon 603 expansion to exert its efficacy.

[0046] The above content is a further detailed description of the present invention in combination with specific implementation methods. It cannot be determined that the specific implementation of the present invention is limited to these descriptions. For ordinary technicians in the technical field to which the present invention belongs, some simple deductions or substitutions can be made without departing from the concept of the present invention, which should be regarded as belonging to the scope of protection determined by the claims submitted for the present invention.

Claims

1. An intracranial drug balloon, characterized in that: The invention comprises a catheter seat (1), a proximal structure, a distal structure and a containing structure, wherein the right end of the catheter seat (1) is connected to a hypotube (2), the outer wall of the hypotube (2) is provided with a visual mark (3), the right end of the hypotube (2) is provided with a proximal structure, the right end of the proximal structure is connected to the distal structure, the right end of the distal structure is provided with a retractable containing structure, the right end of the containing structure is provided with a tip (7), the right end of the tip (7) is connected to a protective wire (8), and the right end of the protective wire (8) is connected to a protective sleeve (9).

2. An intracranial drug balloon according to claim 1, characterized in that: The proximal structure comprises a transition tube (401), the right end of the transition tube (401) is connected to a proximal outer tube (402), and a reinforcing wire (403) is arranged at the center of the proximal outer tube (402).

3. An intracranial drug balloon according to claim 1, characterized in that: The distal structure comprises a side port (501), the right end of the side port (501) is connected to a distal outer tube (502), a distal inner tube (504) is arranged inside the distal outer tube (502), a first nylon tube (505) is arranged inside the distal inner tube (504), a first low-density tube (506) is arranged inside the first nylon tube (505), and a first high-density tube (503) is arranged inside the first low-density tube (506).

4. An intracranial drug balloon according to claim 1, characterized in that: The containing structure comprises a second high-density tube (602), the second high-density tube (602) is externally sheathed with a second low-density tube (606), the outer wall of the second low-density tube (606) is sheathed with a second nylon tube (605), the second nylon tube (605) is externally sheathed with a distal inner tube (604), the distal inner tube (604) is externally provided with a balloon (603), and the balloon (603) is externally provided with a drug coating (601).

5. An intracranial drug balloon according to claim 2, characterized in that: The reinforcing wire (403) is made of stainless steel.

6. An intracranial drug balloon according to claim 3, characterized in that: The first low-density tube (506) and the second low-density tube (606) are both made of linear low-density polyethylene.

7. An intracranial drug balloon according to claim 3, characterized in that: The first high-density tube (503) and the second high-density tube (602) are both made of high-density polyethylene.

8. An intracranial drug-eluting balloon according to claim 3, characterized in that: The first nylon tube (505) and the second nylon tube (605) are both made of nylon elastomer.

9. An intracranial drug balloon according to claim 4, characterized in that: The distal inner tube (604) is provided with a mark inside.